Revolution Medicines (RVMDW) Interest & Investment Income (2019 - 2026)

Revolution Medicines' Interest & Investment Income history runs 8 years deep, the most recent figure standing at $19.5 million for Q1 2026.

• In Q1 2026, Interest & Investment Income fell 21.7% year-over-year to $19.5 million; the TTM figure through Mar 2026 stood at $130.1 million (up 154.32% YoY), while the FY2025 annual figure was $90.7 million, up 4.39% from the prior year.
• Interest & Investment Income for Q1 2026 stood at $19.5 million, down from $88.9 million in the prior quarter.
• The five-year high for Interest & Investment Income was $88.9 million in Q4 2025, with the low at -$1.8 million in Q4 2022.
• The 5-year median for Interest & Investment Income is $1.2 million (2023), against an average of $10.7 million.
• The sharpest annual moves came in 2022 and 2025: Interest & Investment Income plunged 1613.21% in 2022, then jumped 1530.25% in 2025.
• Revolution Medicines' Interest & Investment Income stood at -$1.8 million in 2022, then soared by 180.72% to $1.4 million in 2023, then surged by 1400.0% to $21.2 million in 2024, then soared by 318.84% to $88.9 million in 2025, then slumped by 78.06% to $19.5 million in 2026.
• Business Quant data shows RVMDW's Interest & Investment Income at $19.5 million in Q1 2026, $88.9 million in Q4 2025, and $22.1 million in Q3 2025.